Paratek Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
29 Mar 2023	Form 3: Dondero James D, 10% owner Holds 1,899,770 shares of Common Stock
14 Jun 2021	Form 3: Baylor-Henry Minnie, Director No securities owned
27 Sep 2019	Form 3: Brenner Randall B., Chief Development & Regulatory Holds 41,554 shares of Common Stock
23 Apr 2018	Form 3: Hoffmann Rolf K, Director Holds 3,500 shares of Common Stock
11 Mar 2016	Form 3: Peterson Kristine, Director No securities owned
30 Jul 2015	Form 3: Franson Timothy R, Director No securities owned
02 Jul 2015	Form 3: Haskel William M., Sr. VP, Sec. & General Counsel Holds 1,000 shares of Common Stock
16 Apr 2015	Form 3: Woodrow Adam, VP & Chief Commercial Officer Holds 0 shares of No securities are beneficially owned
22 Dec 2014	Form 3: Pagan Douglas W., Chief Financial Officer No securities owned
10 Nov 2014	Form 3: K/S Danish BioVenture, 10% owner and 1 other Holds 633,243 shares of Common Stock
10 Nov 2014	Form 3: Omega Fund III, L.p., 10% owner and 8 others Holds 1,110,442 shares of Common Stock
05 Nov 2014	Form 3: Hbm Healthcare Investments (Cayman) Ltd., 10% owner Holds 1,768,260 shares of Common Stock
03 Nov 2014	Form 3: Lim Richard J., Director No securities owned
03 Nov 2014	Form 3: Loh Evan, Director No securities owned
03 Nov 2014	Form 3: Bigham Michael, Director No securities owned
03 Nov 2014	Form 3: Boxmeyer Kathryn M., See Remarks No securities owned
03 Nov 2014	Form 3: Radie Robert S, Director No securities owned
03 Nov 2014	Form 3: Stein Jeffrey, Director No securities owned
17 Dec 2013	Form 3: Loar Matthew M, Director Holds 54,755 shares of Common Stock
05 Sep 2013	Form 3: Roumell Asset Management, Llc, 10% owner Holds 1,987,231 shares of Common Stock

Comments